Literature DB >> 17609295

Molecular characterization of 6 unrelated Italian patients with 5alpha-reductase type 2 deficiency.

F Baldinotti1, S Majore, A Fogli, G Marrocco, P Ghirri, M Vuerich, S Tumini, B Boscherini, M Vetri, S Scommegna, R Rinaldi, P Simi, P Grammatico.   

Abstract

Steroid 5alpha-reductase (5alphaR) deficiency (OMIM number #264600) is a rare 46,XY disorder of sex differentiation caused by mutations in the 5alphaR type 2 gene (SRD5A2) resulting in dihydrotestosterone deficiency during fetal development. We report on the analysis of the SRD5A2 gene in 6 unrelated 46,XY Italian patients with external genitalia morphology ranging from predominantly female to nearly completely male. Three subjects were seen and assessed at birth, 1 patient was referred to us before puberty, and 2 at postpubertal age. Six different causative mutations (5 missense and 1 nonsense) and a rare polymorphism were identified. Four patients presented homozygous single-base substitutions. These SRD5A2 mutations were located in exon 2 (variant Cys133Gly), exon 4 (Gly196Ser and Ala207Asp) and exon 5 (Tyr235Phe). A fifth subject was a compound heterozygote who carried a nonsense mutation in exon 1 (Trp53X) and a second SRD5A2 alteration in exon 5 (Tyr235Phe). The final patient presented a mutation in only 1 allele (Gly34Trp) together with the Ala49Thr variant. The molecular characterization of these patients made it possible to identify novel mutations and to confirm, before gender assignment or any surgical approach, the suspected 5alphaR deficiency in 2 newborns, 1 of whom had inconclusive hormonal data. 5alphaR deficiency in subjects without parental consanguinity and the presence of compound heterozygotic patients suggest that SRD5A2 mutations carrier frequency may be higher than previously thought.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609295     DOI: 10.2164/jandrol.107.002592

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  12 in total

1.  Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.

Authors:  M Rahimi; M Ghanbari; Z Fazeli; M Rouzrokh; S Omrani; R Mirfakhraie; M D Omrani
Journal:  J Endocrinol Invest       Date:  2016-11-15       Impact factor: 4.256

2.  The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.

Authors:  N Skordis; V Neocleous; A Kyriakou; E Efstathiou; A Sertedaki; P Philibert; L A Phylactou; S Lumbroso; C Sultan
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

Review 3.  The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Authors:  Abdulmaged M Traish; Ashwini Mulgaonkar; Nicholas Giordano
Journal:  Korean J Urol       Date:  2014-06-16

4.  Screening of Two Neighboring CFTR Mutations in Iranian Infertile Men with Non-Obstructive Azoospermia.

Authors:  Somayeh Heidari; Zohreh Hojati; Majid Motovali-Bashi
Journal:  Int J Fertil Steril       Date:  2016-11-01

5.  Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient.

Authors:  Mesut Parlak; Erdem Durmaz; Semin Gursoy; Iffet Bircan; Sema Akcurin
Journal:  Ann Saudi Med       Date:  2014 May-Jun       Impact factor: 1.526

Review 6.  Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.

Authors:  Rafael Loch Batista; Berenice Bilharinho Mendonca
Journal:  Appl Clin Genet       Date:  2020-04-14

7.  Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study.

Authors:  Paolo Ghirri; Rosa T Scaramuzzo; Silvano Bertelloni; Daniela Pardi; Amerigo Celandroni; Guido Cocchi; Roberto Danieli; Luisa De Santis; Maria C Di Stefano; Orietta Gerola; Mario Giuffrè; Giuseppe S Gragnani; Cinzia Magnani; Cristiano Meossi; Ilaria Merusi; Giuseppe Sabatino; Stefano Tumini; Giovanni Corsello; Antonio Boldrini
Journal:  Ital J Pediatr       Date:  2009-06-27       Impact factor: 2.638

8.  Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development.

Authors:  Dorien Baetens; Wilhelm Mladenov; Barbara Delle Chiaie; Björn Menten; An Desloovere; Violeta Iotova; Bert Callewaert; Erik Van Laecke; Piet Hoebeke; Elfride De Baere; Martine Cools
Journal:  Orphanet J Rare Dis       Date:  2014-12-14       Impact factor: 4.123

9.  Disorders of sex development: a genetic study of patients in a multidisciplinary clinic.

Authors:  Luigi Laino; Silvia Majore; Nicoletta Preziosi; Barbara Grammatico; Carmelilia De Bernardo; Salvatore Scommegna; Anna Maria Rapone; Giacinto Marrocco; Irene Bottillo; Paola Grammatico
Journal:  Endocr Connect       Date:  2014-09-23       Impact factor: 3.335

Review 10.  Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia.

Authors:  Yu Seob Shin; Keshab Kumar Karna; Bo Ram Choi; Jong Kwan Park
Journal:  World J Mens Health       Date:  2018-08-10       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.